These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 17001346

  • 1. Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation.
    Avetisyan G, Larsson K, Aschan J, Nilsson C, Hassan M, Ljungman P.
    Bone Marrow Transplant; 2006 Nov; 38(10):687-92. PubMed ID: 17001346
    [Abstract] [Full Text] [Related]

  • 2. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.
    Avetisyan G, Aschan J, Hägglund H, Ringdén O, Ljungman P.
    Bone Marrow Transplant; 2007 Nov; 40(9):865-9. PubMed ID: 17724444
    [Abstract] [Full Text] [Related]

  • 4. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [Abstract] [Full Text] [Related]

  • 5. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
    Widmann T, Sester U, Gärtner BC, Schubert J, Pfreundschuh M, Köhler H, Sester M.
    PLoS One; 2008 Jul; 3(11):e3634. PubMed ID: 18982061
    [Abstract] [Full Text] [Related]

  • 6. Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.
    Kalpoe JS, van der Heiden PL, Vaessen N, Claas EC, Barge RM, Kroes AC.
    Bone Marrow Transplant; 2007 Jul; 40(2):137-43. PubMed ID: 17530007
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M, Sakurai T, Heike Y, Yamazaki R, Kanda Y, Takaue Y, Mizoguchi H, Kawakami Y.
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen.
    Mohty M, Mohty AM, Blaise D, Faucher C, Bilger K, Isnardon D, Sainty D, Gastaut JA, Viens P, Olive D, Gaugler B.
    Bone Marrow Transplant; 2004 Apr; 33(8):839-46. PubMed ID: 14767500
    [Abstract] [Full Text] [Related]

  • 9. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N, Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, López-Aldeguer N, Hernández-Boluda JC, Remigia MJ, Garcia-Noblejas A, Gimeno C, Navarro D.
    Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
    [Abstract] [Full Text] [Related]

  • 10. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
    Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR.
    Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286
    [Abstract] [Full Text] [Related]

  • 12. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K.
    Transpl Infect Dis; 2010 Aug 01; 12(4):322-9. PubMed ID: 20487414
    [Abstract] [Full Text] [Related]

  • 13. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L.
    Bone Marrow Transplant; 2007 Mar 01; 39(5):293-9. PubMed ID: 17262060
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
    Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, Garcia-Noblejas A, Clari MA, Chilet M, López J, Hernández-Boluda JC, Remigia MJ, Navarro D.
    J Med Virol; 2010 Jul 01; 82(7):1208-15. PubMed ID: 20513086
    [Abstract] [Full Text] [Related]

  • 15. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W, Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C, Cooke JP, Valantine HA, Mocarski ES, Lewis DB.
    Circulation; 2006 Oct 10; 114(15):1608-15. PubMed ID: 17015794
    [Abstract] [Full Text] [Related]

  • 16. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
    Jaskula E, Dlubek D, Duda D, Bogunia-Kubik K, Mlynarczewska A, Lange A.
    Biol Blood Marrow Transplant; 2009 Oct 10; 15(10):1296-305. PubMed ID: 19747638
    [Abstract] [Full Text] [Related]

  • 17. Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.
    Piñana JL, Martino R, Barba P, Margall N, Roig MC, Valcárcel D, Sierra J, Rabella N.
    Bone Marrow Transplant; 2010 Mar 10; 45(3):534-42. PubMed ID: 19668235
    [Abstract] [Full Text] [Related]

  • 18. Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation.
    Pastore D, Delia M, Mestice A, Perrone T, Carluccio P, Gaudio F, Giordano A, Rossi AR, Ricco A, Leo M, Liso V, Specchia G.
    Biol Blood Marrow Transplant; 2011 Apr 10; 17(4):550-7. PubMed ID: 20457268
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation.
    Ljungman P, Perez-Bercoff L, Jonsson J, Avetisyan G, Sparrelid E, Aschan J, Barkholt L, Larsson K, Winiarski J, Yun Z, Ringdén O.
    Haematologica; 2006 Jan 10; 91(1):78-83. PubMed ID: 16434374
    [Abstract] [Full Text] [Related]

  • 20. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS, Mackinnon S.
    Hum Immunol; 2004 May 10; 65(5):550-7. PubMed ID: 15172456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.